{"symbol":"MMC","provider":"yahoo-finance","fetchedAt":"2025-12-25T09:26:04.358Z","asOfDate":"2025-12-25","articles":[{"id":"66f57d2b-d544-3208-b99c-959c49ef1cbd","title":"Marsh & McLennan (MMC): Assessing Valuation After Recent Outperformance and Year-to-Date Share Price Weakness","url":"https://finance.yahoo.com/news/marsh-mclennan-mmc-assessing-valuation-031246806.html","publisher":"Simply Wall St.","publishedAt":"2025-12-25T03:12:46.000Z","relatedTickers":[],"mainIdea":"Marsh & McLennan (MMC): Assessing Valuation After Recent Outperformance and Year-to-Date Share Price Weakness","summary":"Simply Wall St.: Marsh & McLennan (MMC): Assessing Valuation After Recent Outperformance and Year-to-Date Share Price Weakness. Marsh & McLennan Companies (MMC) has quietly outperformed the broader insurance sector over the past month, even as the stock remains down double digits year to date. That gap is where things get interesting. See our latest analysis for Marsh & McLennan Companies. After a weak patch earlier in the year, Marsh & McLennan’s recent 4.5 percent one month share price return and solid five year total shareholder return of roughly 76 percent suggest long term momentum is intact, even if sentiment is..."},{"id":"7f0bb55c-8f9e-3a92-b185-7030adc3184d","title":"Insurance Brokers Stocks Q3 Teardown: Ryan Specialty (NYSE:RYAN) Vs The Rest","url":"https://finance.yahoo.com/news/insurance-brokers-stocks-q3-teardown-033336659.html","publisher":"StockStory","publishedAt":"2025-12-24T03:33:36.000Z","relatedTickers":["RYAN"],"mainIdea":"Insurance Brokers Stocks Q3 Teardown: Ryan Specialty (NYSE:RYAN) Vs The Rest","summary":"StockStory: Insurance Brokers Stocks Q3 Teardown: Ryan Specialty (NYSE:RYAN) Vs The Rest. As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the insurance brokers industry, including Ryan Specialty (NYSE:RYAN) and its peers. Related tickers mentioned: RYAN."},{"id":"fb3989f6-b9e9-3696-9e1e-3fe20aef6ec6","title":"MMC: Lowering target price to $204.00","url":"https://finance.yahoo.com/m/fb3989f6-b9e9-3696-9e1e-3fe20aef6ec6/mmc%3A-lowering-target-price-to.html","publisher":"Argus Research","publishedAt":"2025-12-24T00:00:00.000Z","relatedTickers":[],"mainIdea":"MMC: Lowering target price to $204.00","summary":"Argus Research: MMC: Lowering target price to $204.00. Marsh & McLennan Cos Inc has an Investment Rating of BUY; a target price of $204.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of Medium."}]}
